Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Anne Boulay
Introduction
Anne Boulay is a notable inventor based in Blotzheim, France. She has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment. Her work focuses on identifying biomarkers that can enhance the effectiveness of therapeutic agents.
Latest Patents
Anne Boulay holds a patent titled "p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agent." This patent provides biomarkers for determining the sensitivity of proliferative diseases, such as cancer, to therapeutic agents. Specifically, it addresses the use of mTOR inhibitors in combination with cytotoxic agents that damage or affect the integrity of DNA. This innovation has the potential to improve treatment outcomes for patients suffering from various forms of cancer.
Career Highlights
Throughout her career, Anne Boulay has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in cancer therapies.
Collaborations
Anne has collaborated with esteemed colleagues, including Iwan Beuvink and Heidi Lane. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Anne Boulay's contributions to the field of cancer treatment through her innovative patent and collaborations with leading companies and professionals highlight her significant impact on biomedical research. Her work continues to pave the way for advancements in therapeutic strategies for cancer patients.